Maria Goldaniga
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 23
- Hematology top 5%
- Multiple Myeloma Research and Treatments 7
- Platelet Disorders and Treatments 2
-
- Lymphoma Diagnosis and Treatment 23
-
- Immunodeficiency and Autoimmune Disorders 3
- T-cell and Retrovirus Studies 2
- Nephrology top 10%
-
- Viral-associated cancers and disorders 11
-
- Cutaneous lymphoproliferative disorders research 5
- Co-authors
- Luca BaldiniPaolo G. GobbiGiampaolo MerliniChiara BrogliaMario ComelliStefano LuminariFrancesca Gaia RossiGiorgio La Nasa
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)Blood (8 papers)
- Partner nations
- ItalySwitzerlandUkraine
In The Last Decade
Maria Goldaniga
36 papers receiving 634 citations
Peers
Comparison fields: 5 of 57
- Genetics 302
- Hematology 248
- Pathology and Forensic Medicine 292
- Immunology 141
- Nephrology 47
Countries citing papers authored by Maria Goldaniga
This map shows the geographic impact of Maria Goldaniga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Goldaniga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Goldaniga more than expected).
Fields of papers citing papers by Maria Goldaniga
This network shows the impact of papers produced by Maria Goldaniga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Goldaniga. The network helps show where Maria Goldaniga may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maria Goldaniga, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 38 | |
| 2 | 2020 | 25 | |
| 3 | 2019 | 23 | |
| 4 | 2018 | 7 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 0 | |
| 7 | 2016 | 4 | |
| 8 | 2013 | 18 | |
| 9 | 2013 | 28 | |
| 10 | 2013 | 2 | |
| 11 | 2010 | 10 | |
| 12 | 2008 | 20 | |
| 13 | 2006 | 27 | |
| 14 | CD5 negative chronic B cell leukemias : a polycentric retrospective study | 2005 | 1 |
| 15 | 2005 | 54 | |
| 16 | Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab. | 2004 | 6 |
| 17 | 2003 | 15 | |
| 18 | 2003 | 5 | |
| 19 | 2003 | 18 | |
| 20 | 2002 | 89 |
About Maria Goldaniga
Maria Goldaniga is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 39 papers that have together received 647 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (23 papers), Viral-associated cancers and disorders (11 papers), Multiple Myeloma Research and Treatments (7 papers), Cutaneous lymphoproliferative disorders research (5 papers), Immunodeficiency and Autoimmune Disorders (3 papers), T-cell and Retrovirus Studies (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Genetics (302 citations), Hematology (248 citations) and Pathology and Forensic Medicine (292 citations). Maria Goldaniga has collaborated with scholars based in Italy, Switzerland and Ukraine. Frequent co-authors include Luca Baldini, Paolo G. Gobbi, Giampaolo Merlini, Chiara Broglia, Mario Comelli, Stefano Luminari, Francesca Gaia Rossi, Giorgio La Nasa, Sergio Cortelazzo and Enrica Morra. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.